Andrew C. Olson

Signature Genomic Laboratories LLC was engaged in the provision of diagnostic cytogenetic services. It used microarray technology to diagnose chromosome abnormalities in children with developmental disabilities. The company was founded in 2003 and was headquartered in Spokane, WA.

Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.

GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ.

Fisher Scientific Co. LLC wholesales scientific and engineering equipment. The company supplies organic laboratory, chemicals, allied products, and inorganic chemicals. The company is headquartered in Pittsburgh, PA.

Great Basin Scientific, Inc. is a molecular diagnostic testing company, which focuses on the development and commercialization of its patented, molecular diagnostic platform designed to test for infectious disease, especially hospital-acquired infections. The company was founded by David C. Ward, Anthony R. Torres and David Spafford on June 27, 2003 and is headquartered in Salt Lake City, UT.

Tute Genomics, Inc. develops and provides cloud-based application that delivers genomic insights to genetics research, clinicians and medical practitioners. Its clinical-grade web based application allows researchers and clinicians to analyze, utilize, and interpret human genomes data for scientific discovery and individualized treatment. The firm’s platform also supports disease gene finding and biomarker discovery, as well as provides machine intelligence, genome management, data filtration for streamlined output, and association analysis. The company was founded by Kai Wang and Reid Robison in 2012 and is headquartered in Provo, UT.

Inherent Biosciences, Inc. is a commercial-stage life science company based in Salt Lake City, UT. Inherent Biosciences has developed an epigenetic platform that detects gene dysregulation across multiple genes and related pathways to pioneer a new category of diagnostics and therapeutics that leverage epigenetics, biology's inherent mechanism for gene regulation, to radically transform how we diagnose and treat complex diseases like infertility. The company is actively involved in clinical trials to further validate its diagnostic tools. The company was founded by Kristin Brogaard and Andrew C. Olson, who has been the CEO since incorporation.